Lithium Treatment of Bipolar Affective Disorders under Naturalistic Followup Conditions

Psychopharmacology Bulletin

Volumn 32, Issue 1, 1996, Pages 47-54

  Goldberg, Joseph F ^a,c   Harrow, Martin ^b   Leon, Andrew C ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c New York Hosp Cornell Univ Med C ^*  (United States)

Author keywords

Affective relapse; Bipolar disorders; Followup studies; Lithium; Manic outcome

Indexed keywords

LITHIUM; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; JOB PERFORMANCE; MALE; MANIC DEPRESSIVE PSYCHOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; SOCIAL ADAPTATION; TREATMENT OUTCOME; ARTICLE; BIPOLAR DISORDER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; PATHOPHYSIOLOGY;

ADULT; BIPOLAR DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LITHIUM; MALE; PROGNOSIS;

EID: 0029692913     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Black, DW; Winokur, G; Hulbert, J; and Nasrallah, A. Predictors of immediate response in the treatment of mania: The importance of comorbidity. Biol. Psychiatry 24:191-198, 1988.
2. Coppen, A; Noguera, R; Bailey, J; Burns, BH; Swani, MS; Hare, EH; Gardner, R; and Maggs, R. Prophylactic lithium in affective disorders: A controlled trial. Lancet 2:275-279, 1971.
3. Coryell, W; Endicott, J; Maser, JD; Mueller, T; Lavori, P; and Keller, M. The likelihood of recurrence in bipolar affective disorder: The importance of episode recency. J. Affective Disord. 33:201-206, 1995.
4. Dickson, WE, and Kendell, RE. Does maintenance lithium therapy prevent recurrences of mania under ordinary clinical conditions? Psychol. Med. 16:521-530, 1986.
5. Dunner, DL, and Fieve, RR. Clinical factors in lithium carbonate prophylaxis failure. Arch. Gen. Psychiatry 30:229-233, 1974.
6. Endicott, J, and Spitzer, RL. A diagnostic interview: The Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry 35:837-844, 1978.
7. Garfinkel, PE; Stancer, HC; and Persad, E. A comparison of haloperidol, lithium carbonate, and their combination in the treatment of mania. J. Affective Disord. 2:279-288, 1980.
8. Gelenberg, AJ; Kane, JM; Keller, MB; Lavori, P; Rosenbaum, JF; Cole, K; and Lavelle, J. Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. New Engl. J. Med. 3321:1489-1493, 1989.
9. Goldberg, JF, and Harrow, M. Kindling in bipolar disorders: A longitudinal follow-up study. Biol. Psychiatry 35:70-72, 1994.
10. Goldberg, JF; Harrow, M; and Grossman, LS. Course and outcome in bipolar affective disorder. A longitudinal follow-up study. Am. J. Psychiatry 152:379-384, 1995a.
11. Goldberg, JF; Harrow, M; and Grossman, LS. Recurrent affective syndromes in bipolar and unipolar mood disorders at follow-up. Br. J. Psychiatry 166:382-385, 1995b.
12. Goodnick, PJ, and Meltzer, HY. Treatment of schizoaffective disorders. Schizophr. Bull. 10:30-48, 1984.
13. Grinker, RR Sr, and Harrow M, eds. Clinical Research in Schizophrenia: A Multidimensional Approach. Springfield, IL: Charles C. Thomas, 1987.
14. Harrow, M; Goldberg, JF; Grossman, LS; and Meltzer, HY. Outcome in manic disorders: A naturalistic follow-up study. Arch. Gen. Psychiatry 47:665-671, 1990.
15. Himmelhoch, JM, and Garfinkel, ME. Sources of lithium resistance in mixed mania. Psychopharmacol. Bull. 22:613-620, 1986.
16. Keller, MB; Lavori, PW; Coryell, W; Endicott, J; and Mueller, TI. Bipolar I: A five-year prospective follow-up. J. Nerv. Ment. Dis. 181:238-245, 1993.
17. Kocsis, JH, and Stokes, PE. Lithium maintenance: Factors affecting outcome. Am. J. Psychiatry 136:563-566, 1979.
18. Kukopulos, A; Reginaldi, D; Laddomada, P; Floris, G; Serra, G; and Tondo, L. Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatr. Neuropsychopharmakol. 13:156-167, 1980.
19. Lerer, B. Alternative therapies for bipolar disorder. J. Clin. Psychiatry 46:309-316, 1985.
20. Levenstein, S; Klein, DF; and Pollack, M. Follow-up study of formerly hospitalized voluntary psychiatric patients: The first two years. Am. J. Psychiatry 122:1102-1109, 1966.
21. Mander, AJ. Is lithium justified after one manic episode? Acta Psychiatr. Scand. 73:60-67, 1986.
22. Markar, HR, and Mander, AJ. Efficacy of lithium prophylaxis in clinical practice. Br. J. Psychiatry 155:496-500, 1989.
23. Moss, GR, and James, CR. Carbamazepine and lithium carbonate synergism in mania. Arch. Gen. Psychiatry 40: 588-589, 1983.
24. O'Connell, RA; Mayo, JA; Flatow, L; Cuthbertson, B; and O'Brien, BE. Outcome of bipolar disorder on long-term treatment with lithium. Br. J. Psychiatry 159:123-129, 1991.
25. Overall, JE, and Gorham, DR. The Brief Psychiatric Rating Scale. Psychol. Rep. 10:799-812, 1962.
26. Peselow, ED; Fieve, RR; Difiglia, C; and Sanfilipo, MP. Lithium prophylaxis of bipolar illness: The value of combination treatment. Br. J. Psychiatry 164:208-214, 1994.
27. Prien, RF; Caffey, EM; and Klett, CJ. Prophylactic efficacy of lithium carbonate in manic-depressive illness. Arch. Gen. Psychiatry 28:337-341, 1973.
28. Prien, RF, and Gelenberg, AJ. Alternatives to lithium for preventive treatment of bipolar disorder. Am. J. Psychiatry 146: 840-848, 1989.
29. Prien, RF; Himmelhoch, JM; and Kupfer, DJ. Treatment of mixed mania. J. Affect. Disord. 15:9-15, 1988.
30. Prien, RF; Klett, CJ; and Caffey, EM. Lithium prophylaxis in recurrent affective illness. Am. J. Psychiatry 131:198-203, 1974.
31. Prien, RF; Kupfer, DJ; Mansky, PA; Small, JG; Tuason, VB; Voss, CB; and Johnson, WE. Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch. Gen. Psychiatry 41:1096-1104, 1984.
32. Sachs, G. Use of clonazepam for bipolar affective disorder. J. Clin. Psychiatry 51:31-34, 1990.
33. Sachs, GS; Lafer, B; Truman, CJ; Noeth, M; and Thibault, AB. Lithium monotherapy: Miracle, myth and misunderstanding. Psychiatr. Annals 24:299-306, 1994.
34. Sackett, DL, and Gent, M. Controversy in counting and attributing events in clinical trials. N. Engl. J. Med. 301: 1410-1412, 1979.
35. Sernyak, MJ, and Woods, SW. Chronic neuroleptic use in manic-depressive illness. Psychopharmacol. Bull. 29(3):375-381, 1993.
36. Spitzer, RL; Endicott, J; and Robins, E. Research Diagnostic Criteria: Rationale and reliability. Arch. Gen. Psychiatry 35: 773-782, 1978.
37. Stallone, F; Shelley, E; Mendlewicz, J; and Fieve, RR. The use of lithium in affective disorders, III: A double-blind study of prophylaxis in bipolar illness. Am. J. Psychiatry 130: 1006-1010, 1973.
38. Strauss, JS, and Carpenter, WT. The prediction of outcome in schizophrenia: Characteristics of outcome. Arch. Gen. Psychiatry 27:739-746, 1972.
39. Tohen, M; Waternaux, CM; and Tsuang, M. Outcome in mania: A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch. Gen. Psychiatry 47:1106-1111, 1990.
40. Wehr, TA, and Goodwin, FK. Can antidepressants cause mania and worsen the course of affective illness? Am. J. Psychiatry 144:1403-1411, 1987.
41. Wolpert, EA; Harrow, M; Drake, J; and Goldberg, JF. Outcome in rapid-cycling bipolar manic patients. CME Syllabus and Scientific Proceedings of the 147th Annual Meeting of the American Psychiatric Association, 1994. p. 9.